An evaluation of the real world use and clinical utility of the Cxbladder Monitor assay in the follow-up of patients previously treated for bladder cancer

BACKGROUND: Surveilling recurrent urothelial carcinoma (UC) requires frequent cystoscopy, which is invasive, expensive and time-consuming. An accurate urinary biomarker has the potential to reduce the number of cystoscopies required during post-treatment surveillance. OBJECTIVE: To audit the clinica...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMC Urol
Hlavní autoři: Koya, Madhusudan, Osborne, Sue, Chemaslé, Christophe, Porten, Sima, Schuckman, Anne, Kennedy-Smith, Andrew
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2020
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7014779/
https://ncbi.nlm.nih.gov/pubmed/32046687
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12894-020-0583-0
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky